NCT04480151

ECLS Versus IMPELLA™ as Bridge to LVAD (ECI-BLAD)

ExtraCorporeal Life Support (ECLS) Versus IMPELLA™ Pump as Bridge to Left Ventricular Assist Device

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 92 (actual)
• Sponsor: University Hospital, Bordeaux · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

In this retrospective observational multicenter study the authors tested the hypothesis that the use of IMPELLA™ pump as bridge to bridge, by giving the opportunity of active rehabilitation, should improve patient's outcomes after the implantation of Left Ventricular Assist Device (LVAD).

Detailed description

End stage heart failure patients admitted in Intensive Care Unit (ICU) for refractory cardiogenic shock requiring short-term mechanical circulatory support as a bridge to a long-term LVAD might benefit from early mobilization and rehabilitation with IMPELLA™ inserted via the axillary artery. The aim of this study is to compare the early rehabilitation and outcomes after LVAD implantation between patients previously treated by IMPELLA™ or ExtraCorporeal Life Support (ECLS)

Conditions

• Cardiogenic Shock
• End-stage Heart Failure

Interventions

Type	Name	Description
OTHER	standard of care	retrospective study: standard of care

Timeline

• Start date: 2021-01-20
• Primary completion: 2021-04-21
• Completion: 2021-04-21
• First posted: 2020-07-21
• Last updated: 2021-07-07

Locations

5 sites across 1 country: France